Funding Details
- Awarder
- Gaingels
- Date Award
- May 24, 2024
- Vertical
- Healthcare and Biotech
- Funding URL
- View Funding Page
- Valuation
-
$200,000,017
Company Info
- Founders
- Jonathan Sporn
- Company Description
- Developer of central nervous system drugs intended to treat neurological disorders. Gilgamesh Pharmaceuticals provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety, and stress-related disorders.
- Market
- Healthcare & Wellness
- Coinvestors
- Route 66,Prime Movers Lab Fund II LP,Prime Movers Labs,NLX,Satori Venture,Ambria,CTR Capital,Negev Capital,Ayuh Ventures,Noetic Fund,Gron Ventures,PsyMed Ventures,Palo Santo
Links